| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
74 |
| Employees |
37 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-29 |
| Cash Flow (TTM) (Millions $) |
-37 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
Sio Gene Therapies Inc is a gene therapy company focused on developing, manufacturing, and delivering transformative gene therapies for patients with neurological disorders. The company aims to address the root cause of these disorders by utilizing their proprietary technology platform to deliver gene therapies directly to the brain.
Sio Gene Therapies Inc is committed to advancing gene therapy as a treatment modality through their innovative approach to target the underlying genetic mutations and restore normal gene expression. They have an extensive pipeline of gene therapy candidates aimed at treating various neurological disorders including genetic disorders, neurodegenerative diseases, and rare monogenic conditions.
The company's mission is to bring hope to patients and their families by providing effective and durable treatments for debilitating neurological disorders. They strive to leverage their expertise in gene therapy development and manufacturing to accelerate the development of novel therapies and improve the quality of life for patients.
Company Address: 1501 Broadway New York 10036 NY
Company Phone Number: 677-6770 Stock Exchange / Ticker: NASDAQ SIOX
|
%
0.73% 